China Medical & HealthCare Group Limited provided unaudited consolidated guidance for the five months ended May 31, 2022. For the period, the Group is expected to record a Net Loss for the five months ended 31 May 2022 which represents an approximately 316% increase as compared with the Net Loss for the corresponding period in 2021; an approximately 40% to 50% decrease, when compared with the Net Loss for the six months, ended 30 June 2021; or an approximately 77% to 87% increase, when compared with the Net Loss for the six months, ended 30 June 2021 excluding the one-off non-recurring item of impairment loss recognized on loan receivable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 HKD | 0.00% | 0.00% | -13.75% |
20/05 | Tian an Medicare Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
02/05 | China Medical & HealthCare Changes Name to Tian An Medicare | MT |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 95.94M | |
-25.47% | 15B | |
-1.80% | 11.99B | |
+3.48% | 11.7B | |
+27.17% | 8.59B | |
-6.29% | 7.5B | |
+6.08% | 6.71B | |
+0.89% | 6.02B | |
-4.31% | 4.28B | |
+11.12% | 4.04B |
- Stock Market
- Equities
- 383 Stock
- News Tian An Medicare Limited
- China Medical & HealthCare Group Limited Provides Unaudited Consolidated Guidance for the Five Months Ended May 31, 2022